Journal of Gene Therapy for Genetic Disorders is an international peer reviewed open access journal, which provides a platform for researchers and practitioners everywhere throughout the world to promote, share, and examine distinctive new issues and headways within the scope of the journal.
Gene Therapy has made paramount medical advances in less than two decades. Within a short period of time, it has proceeded from the conceptual stage to technology development and laboratory research and further to clinical translational trials for a mixed bag of lethal ailments. Among the most remarkable progressions in gene therapy, cases of severe combined immune deficiency, chronic granulomatus disorder, hemophilia, congenital blindness, lysosomal storage disease and muscular dystrophy, etc., are the most noticeable ones seen.
The journal disperses unique papers including but not limited to the following fields:
- Classical and Developmental Genetics
- Conservation and Ecological Genetics (Behavioural Genetics)
- Evolutionary and Population Genetics (except Human)
- Genetic Engineering
- Genetics of Plants and Animals in Agronomy Quantitative Genetics)
- Human and Medical Genetics (Quantitative Genetics, Population Genetics, Psychiatric Genetics)
- Microbial Genetics
- Molecular Genetics (Gene Characterization and Polymorphisms, Control of Gene Expression and Epigenetics)
- Technical Tips and Improvement
A global representation on the editorial board will help advance the practice globally and shed light on international approaches in education, practice and research, with a single common objective to study about the treatment of gene deficiency or disorders in cells that leads to the genetic disorders resolved with the gene therapy.